Clinical Trials Browser

Interventional × Bone Diseases, Metabolic × Genitourinary × Clear all

Frailty, Arthritis, Bone Diseases, Metabolic, Cardiovascular Diseases, Chronic Disease, Diabetes Mellitus, Heart Failure, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Stroke

NCT00063609 2017-09-13

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Phase 4 Completed

200 enrolled

Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms

NCT00925600 2017-05-30

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Phase 3 Completed

769 enrolled 21 charts

Genitourinary

Bone Diseases, Metabolic, Cataract, Neoplasms, Osteoporosis, Prostatic Neoplasms

NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

Phase 3 Completed

1,200 enrolled

Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

NCT00181584 2013-07-11

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer

Phase 2 Completed

60 enrolled

Genitourinary

Bone Diseases, Metabolic, Prostatic Neoplasms

Clinical Trials

MoveStrong

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer